Last reviewed · How we verify

Oral Cholera Vaccine (OCV) — Competitive Intelligence Brief

Oral Cholera Vaccine (OCV) (Oral Cholera Vaccine (OCV)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Infectious Diseases.

phase 3 Infectious Diseases Biologic Live · refreshed every 30 min

Target snapshot

Oral Cholera Vaccine (OCV) (Oral Cholera Vaccine (OCV)) — International Centre for Diarrhoeal Disease Research, Bangladesh. The Oral Cholera Vaccine (OCV) works by stimulating the body's immune system to produce antibodies against Vibrio cholerae, the bacteria that causes cholera.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Oral Cholera Vaccine (OCV) TARGET Oral Cholera Vaccine (OCV) International Centre for Diarrhoeal Disease Research, Bangladesh phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oral Cholera Vaccine (OCV) — Competitive Intelligence Brief. https://druglandscape.com/ci/oral-cholera-vaccine-ocv. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: